- RESEARCH HIGHLIGHT
Targeting shared proteins could help to control bacterial subtypes that current vaccines do not protect against.
There are more than 100 subtypes of Streptococcus pneumoniae bacteria (artificially coloured), leading scientists to seek a universal vaccine that would protect against all forms of the pathogen. Credit: James Cavallini/SPL
Scientists are one step closer to developing a universal vaccine against Streptococcus pneumoniae, a bacterium that causes pneumonia and meningitis.
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-02462-z
References
Subjects
Latest on:
- Vaccines
-
Polio will come roaring back if the task of eradicating it isn’t finished soon
Editorial
-
First volunteer gets Ebola vaccine — three months after the outbreak began
News Q&A
-
How does Make America Healthy Again hold up against scientific scrutiny?
Spotlight